Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo CTIC

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib	Cognition Disorders, Cognitive Dysfunction, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cognitive disorder, depressive disorder, epithelial neoplasm, lung adenocarcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, psychiatric disorder, respiratory system disorder, respiratory tract neoplasm	Recruiting	Not stated	2026-06-08		NCT07633626

Clinical trials